Bluejay Diagnostics, Inc. (BJDX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$5.16M
As of 2025-12-31
$9.60M
As of 2026-06-30
-20.1%
3-year compound annual growth
+41.4%
5-year compound annual growth
$19.05M2020-12-31: $912.4K2021-12-31: $19.05M2022-12-31: $10.11M2023-12-31: $2.21M2024-12-31: $4.30M2025-12-31: $5.16M$5.16M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$5.16M+20.1%2026-03-06, Balance as of period end
2024-12-31$4.30M+94.8%2026-03-06, Balance as of period end
2023-12-31$2.21M-78.2%2025-03-31, Balance as of period end
2022-12-31$10.11M-46.9%2024-03-28, Balance as of period end
2021-12-31$19.05Mn/m2023-03-20, Balance as of period end
2020-12-31$912.4Kn/a2022-03-10, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Bluejay Diagnostics, Inc. (BJDX)2025-12-31$5.16M+20.1%
Autonomix Medical, Inc. (AMIX)2026-03-31$7.00M-23.3%
Glucotrack, Inc. (GCTK)2025-12-31$7.38M+31.4%
Biotricity Inc. (BTCY)2026-03-31$149.8K-59.0%
Aethlon Medical Inc (AEMD)2026-03-31$5.03M-8.6%
RenovoRx, Inc. (RNXT)2025-12-31$7.02M-1.8%
HeartBeam, Inc. (BEATW)2025-12-31$4.38M+84.3%
QTREX Quantum Ltd. (QTEX)2025-12-31$3.16M-38.2%
Sintx Technologies, Inc. (SINT)2025-12-31$4.14M+15.1%

Compare BJDX, AMIX, GCTK, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗